Sodium Chloride Grifols 0.9% Solution for infusion BP
Sodium Chloride Grifols 0.9% Solution for infusion BP
What it does
Grifols is a medication used to treat certain medical conditions, though specific details about its actions and effects are not provided.
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:03 · updated 2026-09-21 02:30:19
About this medicine
Grifols is a medication used to treat certain medical conditions, though specific details about its actions and effects are not provided.
How it works
The exact way Grifols works is not detailed, but it is generally used for specific therapeutic purposes.
Who it's for
Grifols is indicated for patients with specific health needs as determined by a healthcare provider.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: grifols
Grifols is a pharmaceutical company that specializes in the production of plasma-derived medicines and other biopharmaceutical products. It focuses on therapies for conditions such as hemophilia, immunodeficiencies, and critical care. The products developed by Grifols are derived from human plasma and are used to replace or supplement deficient or absent proteins in patients.
Indications
- Hemophilia A and B
- Primary immune deficiency disorders
- Secondary immune deficiency disorders
- Hypogammaglobulinemia
- Sepsis
- Acute bleeding episodes
Dosage
Children: Refer to specific product guidelines for paediatric dosing, as it may vary based on the indication and product formulation.
Adults: Refer to specific product guidelines for adult dosing, as it may vary based on the indication and product formulation.
Mechanism of action
Grifols' products, such as immunoglobulins and clotting factors, work by replacing or supplementing specific proteins that are missing or deficient in patients. Immunoglobulins function by binding to pathogens, neutralizing their effects and facilitating their elimination by the immune system. Clotting factors restore the coagulation cascade, thereby improving hemostasis in patients with bleeding disorders.
Pharmacodynamics
The pharmacodynamics of Grifols products depend on the specific protein being administered. In the case of immunoglobulins, their binding to pathogens and modulation of immune responses enhance the body's ability to fight infections. Clotting factors interact with other components in the coagulation pathway to promote thrombin generation and ultimately lead to clot formation, helping to prevent or control bleeding.
Pharmacokinetics
Pharmacokinetics vary by product but generally include absorption through intravenous or intramuscular administration, distribution in the extracellular fluid, metabolism primarily in the liver, and excretion through the kidneys. The half-life of immunoglobulins can range from 21 to 30 days, while clotting factors may have shorter half-lives depending on their formulation.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.